Workflow
Globenewswire
icon
搜索文档
PMGC Holdings Inc. Completes Acquisition of Custom IT Packaging Company Pacific Sun Packaging with Over $2,000,000 in Combined Revenue for Fiscal Years 2023 and 2024
Globenewswire· 2025-07-10 20:30
Serves over 300 Commercial Clients including Data Centers, Technology Manufacturers and Information Technology (IT) Service Providers.Adds cash flow positive revenue, enhances PMGC’s exposure to U.S. semiconductor and artificial intelligence (“AI”) infrastructure growth, and marks the launch of its strategic acquisition program targeting U.S. businesses. NEWPORT BEACH, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (Nasdaq: ELAB) (the “Company,” “PMGC,” “we,” or “us”), a diversified public hol ...
AmpliTech Group Poised to Benefit from New Federal “One Big Beautiful Bill” Supporting Private 5G and ORAN Rollouts
Globenewswire· 2025-07-10 20:30
HAUPPAUGE, N.Y., July 10, 2025 (GLOBE NEWSWIRE) -- AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components and complete 5G/6G systems, including advanced Open RAN (ORAN) radios for private and public 5G networks, announced that the recently signed One Big Beautiful Bill (OBBB), as per below company internal analysis, positions the company for accelerated growth in the 5G and ORAN markets. Spectrum Access The landmark OBBB legislat ...
Intelligent Bio Solutions to Present PK Study Data at Association for Diagnostics and Laboratory Medicine 2025 Clinical Lab Expo
Globenewswire· 2025-07-10 20:30
文章核心观点 - 智能生物解决方案公司将在ADLM 2025临床实验室博览会上展示药代动力学研究数据,表明指纹汗液检测是无创诊断测试的可行选择,公司致力于创新并在检测领域不断拓展 [2][3][4] 公司动态 - 公司将于7月27 - 31日在伊利诺伊州芝加哥举行的ADLM 2025临床实验室博览会上展示药代动力学研究数据 [2] - 公司临床事务主管丹尼尔·布朗将代表公司参加活动,在ADLM海报厅展示研究背景、方法和结果,并与参会者直接交流 [4] 研究成果 - 药代动力学研究收集人类指纹汗液样本进行分析,使用公司的智能指纹药物筛查系统,数据显示指纹汗液中可待因的速率和程度与血液和唾液中一致,是可待因摄入的有力指标 [3] - 95%置信水平的统计比较表明指纹汗液是可靠的药物检测样本基质,定量药代动力学数据与血液检测结果高度一致 [3] 行业活动 - ADLM 2025是全球领先的实验室医学博览会,汇聚国际领袖、科学家和创新者,有超300位专家演讲、250多个教育课程和200多个产品类别 [5] - 活动与加拿大临床化学家协会合作举办,涵盖从人工智能、质谱到颠覆性技术和诊断进展等广泛主题 [6] 公司产品与市场 - 公司的药物筛查系统旨在支持工作场所、治疗和司法环境中的准确、体面和高效检测,在24个国家拥有超450个客户账户 [7] - 公司的智能指纹药物筛查系统通过指纹汗液分析有望革新便携式检测,可检测工作场所常见药物,采样数秒、出结果不到十分钟 [8] - 公司美国以外的客户群体包括建筑、制造、工程、运输、物流、采矿、药物治疗组织和验尸官等 [8]
KULR Expands Bitcoin Holdings to 1,021 BTC, Reports 291.2% BTC Yield
Globenewswire· 2025-07-10 20:30
文章核心观点 公司宣布增加比特币持仓,符合其比特币储备战略,同时介绍了BTC Yield等关键指标及相关考量因素 [1][2] 比特币持仓情况 - 公司额外收购约1000万美元比特币,使比特币收购总额达约1.01亿美元,加权平均价格为每枚108,884美元,现持有1,021枚比特币 [1] 比特币储备战略 - 公司于2024年12月4日宣布比特币储备战略,承诺将至多90%的过剩现金储备用于持有比特币 [2][11] 关键绩效指标 - 公司使用“BTC Yield”作为比特币储备战略的关键绩效指标,计算方式为公司比特币持仓与假设完全摊薄流通股之比的期间百分比变化,有助于评估比特币收购战略对股东价值的推动效果 [3][4] - BTC Gain是将BTC Yield应用于公司给定时期的初始比特币余额,显示公司通过增值行动有效产生的额外比特币数量;BTC $ Gain是将BTC Gain乘以期末比特币价格换算成美元;mNAV是净资产价值倍数,计算方式为市值除以(比特币价格×比特币数量) [5] - 年初至今,公司BTC Yield为291.2%,BTC Gain为633,BTC $ Gain为70,309,152美元,mNAV为2.24 [3][6] 重要考量 - BTC Yield旨在提供公司比特币收购战略的见解,但不应被视为运营绩效、财务回报或流动性的衡量标准,不等同于传统收益率指标,也未考虑公司负债或更广泛的财务状况 [7] - 公司普通股交易价格受多种因素影响,BTC Yield不能预测或反映股票市值,投资者应将其作为补充工具,并参考公司财务报表和SEC文件获取更多财务信息 [8] 公司简介 - 公司是一家比特币优先公司,利用内部电池设计专业知识、全面的电池测试套件以及电池制造和生产能力,为太空、航空航天和国防领域提供前沿储能解决方案 [11]
Dentsply Sirona to Host Second Quarter Conference Call on August 7th
Globenewswire· 2025-07-10 20:30
文章核心观点 - 登士柏西诺德公司宣布将于2025年8月7日上午8点30分举办投资者电话会议和网络直播,以回顾2025财年第二季度财务业绩 [1] 会议信息 - 网络直播将在公司网站投资者板块https://investor.dentsplysirona.com进行 [2] - 参加电话会议需在https://register-conf.media-server.com/register/BI53ec0a63538f4269bf74d4ce11a882e4注册 [2] - 会议结束后可在公司网站投资者板块观看网络直播回放 [2] 公司介绍 - 登士柏西诺德是全球最大的专业牙科产品和技术多元化制造商,拥有超百年创新历史,为全球牙科行业和患者服务 [3] - 公司开发、制造和销售包括牙科和口腔健康产品及其他一次性医疗设备在内的综合解决方案,旗下拥有一系列世界级品牌 [3] - 公司创新产品提供高质量、有效且互联的解决方案,以推进患者护理并提供更好、更安全的牙科治疗 [3] - 公司总部位于北卡罗来纳州夏洛特,其股票在美国纳斯达克以代码XRAY上市 [3] 联系方式 - 投资者可联系副总裁Andrea Daley,电话+1 - 704 - 591 - 8631,邮箱InvestorRelations@dentsplysirona.com [4]
PainReform Ltd. enters into a Strategic Investment Agreement to Expand its Non-Opiate Pain Management Pipeline into Opthamology with LayerBio
Globenewswire· 2025-07-10 20:30
This Investment will add a differentiated ophthalmic platform, targeting an estimated 3 million annual U.S. cataract surgeries with long-acting, “dropless” pain and inflammation treatmentTEL AVIV, Israel, July 10, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), today announced, through its pharmaceutical division, the signing of a strategic investment agreement with LayerBio Inc., a privately held Boston biotechnology company developing proprietary, long-acting, non-opiate treatments for ophthalmic ...
Jamf to Report Second Quarter 2025 Financial Results on August 7, 2025
Globenewswire· 2025-07-10 20:30
MINNEAPOLIS, July 10, 2025 (GLOBE NEWSWIRE) -- Jamf (NASDAQ: JAMF), the standard in managing and securing Apple at work, announced today it will report second quarter financial results for the period ended June 30, 2025, following the close of the market on Thursday, August 7, 2025. On that day, management will host a conference call and webcast at 3:30 p.m. CT (4:30 p.m. ET) to discuss the company’s business and financial results. Jamf Second Quarter 2025 Earnings Conference Call When: Thursday, August 7, ...
Blink Charging and Axxeltrova Capital Agree to Pursue £100 Million Special Purpose Vehicle to Enhance LEVI Projects Across the UK
Globenewswire· 2025-07-10 20:30
The Special Purpose Vehicle will enable acceleration of public EV charging infrastructure, leveraging support from the LEVI initiative. London, UK, July 10, 2025 (GLOBE NEWSWIRE) -- Blink Charging Co. (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global owner, operator, and provider of electric vehicle (EV) charging equipment and services, today announced that on June 20, 2025 it has entered into a non-binding term sheet with respect to the Company’s previously proposed £100 million Special Purpose ...
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment
Globenewswire· 2025-07-10 20:30
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Calidi Biotherapeutics Inc. (NYSE American: CLDI) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “Breaking Through: Systemic Genetic Medicines f ...
Toro Corp. Announces the Sale of the LPG Carrier Dream Syrax
Globenewswire· 2025-07-10 20:30
LIMASSOL, Cyprus, July 10, 2025 (GLOBE NEWSWIRE) -- Toro Corp. (NASDAQ: TORO) (“Toro”, or the “Company”), a global energy transportation services provider, announces that it has entered into an agreement with a wholly owned subsidiary of Robin Energy Ltd. (“Robin”), a Nasdaq-listed entity controlled by our Chairman and Chief Executive Officer, for the sale of the Dream Syrax a 2015-built 5,000 cbm LPG Carrier vessel for a sale price of $18 million. The terms of the transaction were approved by the independe ...